Springer Nature is making SARS-CoV-2 and COVID-19 research free. View research | View latest news | Sign up for updates

Mindfulness-Based Relapse Prevention for Substance Use Disorders: Effects on Cardiac Vagal Control and Craving Under Stress

Abstract

Mindfulness-based relapse prevention (MBRP) is a therapy for addictive behaviors that incorporates cognitive-behavioral relapse prevention (RP) skills with mindfulness training to increase awareness and skillful action in high-risk situations. Stress is a common reason reported for substance use relapse, and using physiological measures to measure stress engagement may help us identify mechanisms of clinical improvement. Specifically, salutatory changes in HF-HRV post-treatment may serve as a marker of treatment efficacy. We investigated tonic and phasic heart rate variability (HRV) to a cognitive stressor (i.e., arithmetic challenge) following 8 weeks of RP, MBRP, or post-detox treatment known as treatment as usual (TAU; n = 34). MBRP was related to higher levels of tonic and phasic HF-HRV, lower levels of anxiety, and lower heart rate reactivity (than TAU only) compared to RP and TAU. This suggests that those who completed MBRP are engaging with stress, but perhaps in a more adaptive, flexible manner. MBRP is associated with higher cardiac vagal control and lower stress/anxious reactivity. Given that negative emotions are an important component of relapse, these results lend further support to say that mindfulness may be helpful for those with substance use disorders.

This is a preview of subscription content, log in to check access.

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5
Fig. 6

References

  1. Aiken, L., & West, S. (1991). Multiple regression: testing and interpreting interactions. Newbury Park: Sage Publications.

  2. Allen, J. J. B., Chambers, A. S., & Towers, D. N. (2007). The many metrics of cardiac chronotropy: a pragmatic primer and a brief comparison of metrics. Biological Psychology, 74(2), 243–262. doi:https://doi.org/10.1016/j.biopsycho.2006.08.005.

  3. Bai, X., Li, J., Zhou, L., & Li, X. (2009). Influence of the menstrual cycle on nonlinear properties of heart rate variability in young women. AJP: Heart and Circulatory Physiology, 297(2), H765–H774. doi:https://doi.org/10.1152/ajpheart.01283.2008.

  4. Balogh, S., Fitzpatrick, D. F., Hendricks, S. E., & Paige, S. R. (1993). Increases in heart rate variability with successful treatment in patients with major depressive disorder. Psychopharmacology Bulletin, 29(2), 201–206.

  5. Beauchaine, T. (2001). Vagal tone, development, and Gray’s motivational theory: toward an integrated model of autonomic nervous system functioning in psychopathology. Development and Psychopathology, 13, 183–214.

  6. Bernston, G. G., Bigger, T., Eckberg, D. L., Grossman, P., Kaufmann, P. G., Malik, M., … Van de Molen, M. W. (1997). Heart rate variability: origins, methods, and interpretive caveats. Psychophsyiology, 34, 623–648.

  7. Bowen, S., Witkiewitz, K., Dillworth, T. M., Chawla, N., Simpson, T. L., Ostafin, B. D., … Marlatt, G. A. (2006). Mindfulness meditation and substance use in an incarcerated population. Psychology of Addictive Behaviors, 20(3), 343–347. doi: https://doi.org/10.1037/0893-164X.20.3.343.

  8. Bowen, S., Chawla, N., Collins, S. E., Witkiewitz, K., Hsu, S., Grow, J., … Marlatt, A. (2009). Mindfulness-based relapse prevention for substance use disorders: a pilot efficacy trial. Substance Abuse, 30(4), 295–305. doi: https://doi.org/10.1080/08897070903250084.

  9. Bowen, S., Chawla, N., Marlatt, G. A., & Parks, G. A. (2010). Mindfulness-based relapse prevention. New York: Guilford.

  10. Bowen, S., Witkiewitz, K., Clifasefi, S. L., Grow, J., Chawla, N., Hsu, S. H., et al. (2014). Relative efficacy of mindfulness-based relapse prevention, standard relapse prevention, and treatment as usual for substance use disorders: a randomized clinical trial. JAMA Psychiatry, 71(5), 547–556. doi:https://doi.org/10.1001/jamapsychiatry.2013.4546.

  11. Brady, K., & Sinha, R. (2005). Co-occurring mental and substance use disorders: the neurobiological effects of chronic stress. American Journal of Psychiatry, 162, 1483–1493.

  12. Brewer, J. A., Sinha, R., Chen, J. A., Michalsen, R. N., Babuscio, T. A., Nich, C., … Rounsaville, B. J. (2009). Mindfulness training and stress reactivity in substance abuse: results from a randomized, controlled stage I pilot study. Substance Abuse, 30(4), 306–317. doi: https://doi.org/10.1080/08897070903250241.

  13. Brownwell, K., Marlatt, G. A., Lichtenstein, E., & Wilson, G. T. (1986). Understanding and preventing relapse. American Psychologist, 41, 765–782.

  14. Bylsma, L., Salomon, K., Taylor-Clift, A., Morris, B. H., & Rottenberg, J. (2014). Respiratory sinus arrhythmia reactivity in current and remitted major depressive disorder. Psychosomatic Medicine, 76, 66–73.

  15. Carpenter, M. J., Upadhyaya, H. P., LaRowe, S. D., Saladin, M. E., & Brady, K. (2006). Menstrual cycle phase effects on nicotine withdrawal and cigarette craving: a review. Nicotine & Tobacco Research, 8, 627–638.

  16. Castaldo, R., Melillo, P., Casterta, M., Triassi, M., & Pecchia, L. (2015). Acute mental stress assessment via short term HRV analysis in healthy adults: a systematic review with meta-analysis. Biomedical Signal Processing and Control, 18, 370–377.

  17. Chalmers, J. A., Quintana, D. S., Maree, J., Abbott, A., & Kemp, A. H. (2014). Anxiety disorders are associated with reduced heart rate variability: a meta-analysis. Frontiers in Psychiatry, 5(80), 1–11.

  18. Chambers, A. S., & Allen, J. (2002). Vagal tone as an indicator of treatment response in major depression. Psychophysiology, 39(6), 861–864. doi:https://doi.org/10.1017/S0048577202010442.

  19. Cohen, H., Kotler, M., Matar, M. A., Kaplan, Z., Miodownik, H., & Cassuto, Y. (1997). Power spectral analysis of heart rate variability in posttraumatic stress disorder patients. Biological Psychiatry, 41, 627–629.

  20. Cohen, H., Kotler, M., Matar, M. A., Kaplan, Z., Lowenthal, U., Miodownik, H., & Cassuto, Y. (1998). Analysis of heart rate variability in posttraumatic stress disorder patients in response to a trauma-related reminder. Biological Psychiatry, 44, 1054–1059.

  21. Conrad, M., Gorka, S. M., & Kassel, J. (2015). Smoking’s effects on respiratory sinus arrhythmia in adolescent smokers. International Journal of Psychophysiology, 97, 8–13.

  22. Dawson, D. A., Grant, B. F., Stinson, F. S., Chou, P. S., Huang, B., & Ruan, W. (2005). Recovery from DSM-IV alcohol dependence: United States, 2001–2002. Addiction, 100(3), 281–292.

  23. Diagnostic and statistical manual of mental disorders: DSM-5. (2013). Washington DC: American Psychiatric Association.

  24. Ditto, B., Eclache, M., & Goldman, N. (2006). Short-term autonomic and cardiovascular effects of mindfulness body scan meditation. Annals of Behavioral Medicine, 32(3), 227–234.

  25. Fox, H. C., & Sinha, R. (2009). Sex differences in drug-related stress-system changes: implications for treatment in substance-abusing women. Harvard Review of Psychiatry, 17, 103–119.

  26. Friedman, B., & Thayer, J. F. (1998). Autonomic balance revisited: panic anxiety and heart rate variability. Journal of Psychiatric Research, 44, 133–151.

  27. Garland, E. L. (2011). Trait mindfulness predicts attentional and autonomic regulation of alcohol cue-reactivity. Journal of Psychophysiology, 25(4), 180–189. doi:https://doi.org/https://doi.org/10.1027/0269-8803/a000060.

  28. Gronwall, D. M. A. (1977). Paced auditory serial-addition task: a measure of recovery from concussion. Perceptual and Motor Skills, 44, 367–373.

  29. Grossman, P., & Taylor, E. W. (2007). Toward understanding respiratory sinus arrhythmia: relations to cardiac vagal tone, evolution and biobehavioral functions. Biological Psychology, 74, 263–285.

  30. Ingaldsson, J. T., Laberg, J. C., & Thayer, J. F. (2003). Reduced heart rate variability in chronic alcohol abuse: relationship with negative mood, chronic thought suppression, and compulsive drinking. Biological Psychiatry, 54, 1427–1436. doi:https://doi.org/10.1016/s0006-3223(02)01926-1.

  31. Kabat-Zinn, J. (1990). Full catastrophe living: using the wisdom of your mind and body to face stress, pain, and illness. New York: Delacorte.

  32. Koob, G. F. (2008). A role for brain stress systems in addiction. Psychology, 83, 84–92.

  33. Libby, D. J., Worhunsky, P. D., Pilver, C. E., & Brewer, J. A. (2012). Meditation-induced changes in high-frequency heart rate variability predict smoking outcomes. Frontiers in Human Neuroscience, 6(54), 1–8. doi:https://doi.org/10.3389/fnhum.2012.00054.

  34. Lustyk, M. K. B., Olson, K. C., Gerrish, W. G., Holder, A., & Widman, L. (2010). Psychophysiological and neuroendocrine responses to laboratory stressors in women: implications of menstrual cycle phase and stressor type. Biological Psychology, 83(2), 84–92. doi:https://doi.org/10.1016/j.biopsycho.2009.11.003.

  35. Lustyk, M. K. B., Gerrish, W. G., Douglas, H., Bowen, S., & Marlatt, G. A. (2011). Relationships among premenstrual symptom reports, menstrual attitudes, and mindfulness. Mindfulness, 2(1), 37–48. doi:https://doi.org/10.1007/s12671-011-0041-x.

  36. Marlatt, G. A., & Donovan, D. M. (2005). Relapse prevention: maintenance strategies in the treatment of addictive behaviors. New York: Guilford.

  37. Marlatt, G. A., & Gordon, J. R. (1985). Relapse prevention: a self-control strategy for the maintenance of behavior change. New York: Guilford.

  38. McLellan, A. T., Lewis, D. C., O’Brien, C. P., & Kleber, H. D. (2000). Drug dependence, a chronic medical illness: implications for treatment, insurance, and outcomes evaluation. JAMA, 284, 1689–1695.

  39. Merikangas, K. R., & McClair, V. L. (2012). Epidemiology of substance use disorders. Human Genetics, 131(6), 779–789.

  40. Middleton, H. C., & Ashby, M. (1995). Clinical recovery from panic disorder is associated with evidence of changes in cardiovascular regulation. Acta Psychiatrica Scandinavica, 91, 108–113.

  41. Minami, J., Ishimitsu, T., & Matsuoka, H. (1999). Effects of smoking cessation on blood pressure and heart rate variability in habitual smokers. Hypertension, 33(1), 586–590.

  42. Otto, M., Powers, M., & Fischmann, D. (2005). Emotional exposure in the treatment of substance use disorders: conceptual model, evidence, and future directions. Clinical Psychology Review, 25, 824–839.

  43. Porges, S. W. (2005). A phylogenetic perspective. In C. S. Carter, L. Ahnert, K. E. Grossmann, & S. B. Hrdy (Eds.), Attachment and bonding: A new synthesis (pp. 33–54). Cambridge: MIT Press.

  44. Porges, S. W. (2007). A phylogenetic journey through the vague and ambiguous Xth cranial nerve: a commentary on contemporary heart rate variability research. Biological Psychology, 74(2), 301–307. doi:https://doi.org/10.1016/j.biopsycho.2006.08.007.

  45. Quintana, D. S., Guastella, A. J., McGregor, I. S., Hickie, I. B., & Kemp, A. H. (2013). Heart rate variability predicts alcohol craving in alcohol dependent outpatients: further evidence for HRV as a psychophysiological marker of self-regulation. Drug and Alcohol Dependence, 132, 395–398.

  46. Rehm, J., Mathers, C., Popova, S., Thavorncharoensap, M., Teerawattananon, Y., & Patra, J. (2009). Global burden of disease and injury and economic cost attributable to alcohol use and alcohol-use disorders. The Lancet, 373, 2223–2233.

  47. Results from the 2009 National Survey on Drug Use and Health: Volume I. Summary of national findings. Office of Applied Studies, NSDUH Series H-38A, HHS. (2010) (Vol. Publication, No. SMA 10–4586). Rockville, MD: SAMSHA.

  48. Rossy, L. A., & Thayer, J. F. (1998). Fitness and gender-related differences in heart period variability. Psychosomatic Medicine, 60(6), 773–781.

  49. Sarang, P., & Telles, S. (2006). Effects of two yoga based relaxation techniques on heart rate variability (HRV). International Journal of Stress Management, 13, 460–475.

  50. Sato, N., Miyake, S., Akatsu, J. L., & Kumashiro, M. (1995). Power spectral analysis of heart rate variability in healthy young women during the normal menstrual cycle. Psychosomatic Medicine, 57, 331–335.

  51. Sinha, R. (2001). How does stress increase risk of drug abuse and relapse? Psychopharmacology, 158, 343–359. doi:https://doi.org/10.1007/s002130100917.

  52. Sinha, R. (2007). The role of stress in addiction relapse. Current Psychiatry Reports, 9, 388–395.

  53. Sinha, R., & O’Malley, S. (1999). Craving for alcohol: findings from the clinic and the laboratory. Alcohol and Alcoholism, 34, 223–230.

  54. Spielberger, C. D., Gorsuch, R. L., & Lushene, R. E. (1982). Manual for the STAI.

  55. Tang, Y.-Y., Ma, Y., Fan, Y., Feng, H., Wang, J., Feng, S., … ... & Zhang, Y. (2009). Central and autonomic nervous system interaction is altered by short-term meditation. Proceedings of the National Academy of Sciences, 106(22), 8865–8870.

  56. Thayer, J. F., & Lane, R. D. (2000). A model of neurovisceral integration in emotion regulation and dysregulation. Journal of Affective Disorders, 61, 201–216.

  57. Thayer, J. F., & Lane, R. D. (2009). Claude Bernard and the heart–brain connection: further elaboration of a model of neurovisceral integration. Neuroscience & Biobehavioral Reviews, 33(2), 81–88. doi:https://doi.org/10.1016/j.neubiorev.2008.08.004.

  58. Thayer, J. F., Friedman, B., & Borkovec, T. (1996). Autonomic characteristics of genderalized anxiety disorder and worry. Biological Psychiatry, 39, 255–266.

  59. Thayer, J. F., Ahs, F., Fredrikson, M., Sollers, J., & Wagner, T. (2012). A meta-analysis of heart rate variability and neuroimaging studies: implications for heart rate variability as a marker of stress and health. Neuroscience & Biobehavioral Reviews, 36, 747–756.

  60. Westbrook, C., Creswell, J. D., Tabibnia, G., Julson, E., Kober, H., & Tindle, H. A. (2013). Mindful attention reduces neural and self-reported cue-induced craving in smokers. Social Cognitive and Affective Neuroscience, 8(1), 73–84. doi:https://doi.org/10.1093/scan/nsr076.

  61. Witkiewitz, K., & Bowen, S. (2010). Depression, craving, and substance use following a randomized trial of mindfulness-based relapse prevention. Journal of Consulting and Clinical Psychology, 78(3), 362–374. doi:https://doi.org/10.1037/a0019172.

  62. Witkiewitz, K., Bowen, S., Douglas, H., & Hsu, S. H. (2013). Mindfulness-based relapse prevention for substance craving. Addictive Behaviors, 38, 1563–1571.

Download references

Funding

This study was funded by the National Center for Research Resources (grant number UL1RR025014).

Author information

HAC: assisted in design of the study, executed the study, and collaborated in the writing of the study. MKBL: designed the study, analyzed the data, and collaborated in the writing of the study.

Correspondence to Haley Carroll.

Ethics declarations

Conflict of Interest

The authors declare that they have no conflict of interest.

Ethical Approval

All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.

Informed Consent

Informed consent was obtained from all individual participants included in the study.

Rights and permissions

Reprints and Permissions

About this article

Verify currency and authenticity via CrossMark

Cite this article

Carroll, H., Lustyk, M.K.B. Mindfulness-Based Relapse Prevention for Substance Use Disorders: Effects on Cardiac Vagal Control and Craving Under Stress. Mindfulness 9, 488–499 (2018). https://doi.org/10.1007/s12671-017-0791-1

Download citation

Keywords

  • Mindfulness
  • Substance use
  • Cardiac vagal control
  • Heart rate variability
  • Stress